Moderna has withdrawn its application to approve the influenza-Covid-19 combination vaccine, intending to resubmit the application with additional data later
Miruna Brosban
Health
sursa foto: pexels.com
Always see our news on Google
The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
20:04
Olga Stefanîșina, former ambassador of Ukraine to the USA, is being investigated by Ukrainian anti-corruption officials.
20:02
The Chamber of Deputies adopts the national strategy for biodiversity conservation, with 177 votes "in favor".
19:59
BCR offered three Inspiration Awards, each worth 5,000 lei, to high schools that impressed with their educational mission.
19:50
Families with children in Kramatorsk, Ukraine, are receiving evacuation orders due to Russian attacks approaching the city.
19:44
The Bucharest Court of Appeal has decided that the DNA indictment against Florian Coldea, Dumitru Dumbravă, and Doru Trăilă is legal, allowing the commencement of the trial.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
.webp)
